Old Web
English
Sign In
Acemap
>
authorDetail
>
Jhm Schellens
Jhm Schellens
Netherlands Cancer Institute
Medicine
Tamoxifen
Estrogen receptor
Pharmacokinetics
Cancer
5
Papers
176
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Cost-effectiveness of monitoring endoxifen levels in breast cancer patients adjuvantly treated with tamoxifen
2018
Breast Cancer Research and Treatment
M. van Nuland
Rick A. Vreman
R.M.T. ten Ham
A. H. M. de Vries Schultink
Hilde Rosing
Jhm Schellens
Jos H. Beijnen
Anke M. Hövels
Show All
Source
Cite
Save
Citations (7)
Identification of OAT1/OAT3 as Contributors to Cisplatin Toxicity
2017
Clinical and Translational Science
Shuiying Hu
Alix F. Leblanc
Alice A. Gibson
K W Hong
J.-Y. Kim
Laura J. Janke
Lie Li
Aksana Vasilyeva
D B Finkelstein
Jason A. Sprowl
D H Sweet
Eberhard Schlatter
Giuliano Ciarimboli
Jhm Schellens
Sharyn D. Baker
Navjotsingh Pabla
Alex Sparreboom
Show All
Source
Cite
Save
Citations (29)
Bioanalytical methods for determination of tamoxifen and its phase I metabolites: A review
2010
Analytica Chimica Acta
S.F. Teunissen
Hilde Rosing
A. H. Schinkel
Jhm Schellens
Jos H. Beijnen
Show All
Source
Cite
Save
Citations (34)
Trabectedin (YondelisTM, formerly ET-743), a mass balance study in patients with advanced cancer
2005
Investigational New Drugs
Jan H. Beumer
Jeany M. Rademaker-Lakhai
Hilde Rosing
Luis López Lázaro
Jos H. Beijnen
Jhm Schellens
Show All
Source
Cite
Save
Citations (29)
1